“…The surgical program grew to include patients from Syria and Yemen. 5 Existing orthopedic infection was found to be common in patients at program entry, and the prevalence of multidrug-resistant pathogens was high. 6,7 To optimize management of chronic trauma-related infections, a medical-surgical strategy was established, a collaboration with a local microbiology laboratory was developed, and broad-spectrum antibiotics, including glycopeptides (vancomycin), extendedspectrum aminoglycosides (amikacin), and carbapenems (imipenem), active against multidrug-resistant strains, were introduced for the first time in an MSF hospital.…”